Society Logo
ME/CFS Australia Ltd
Please click here to donate ME/CFS South Australia Inc
 
 
Facebook
 
ME/CFS SOUTH AUSTRALIA INC

Registered Charity 3104

Email:
sacfs@sacfs.asn.au

Mailing address:

PO Box 322,
Modbury North,
South Australia 5092

Phone:
1300 128 339

Office Hours:
Monday - Friday,
10am - 4pm
(phone)

ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

Disclaimer

ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Become a Member
DOCX Application Form (Word, 198 KB)
Why become a member?

Promising Treatment For Chronic Fatigue Syndrome Fails Large Trial

Sunday 14 April 2019

 

From New Scientist:

 

Man with glasses
(Photo: iStock / Getty Images Plus)
 

Promising treatment for chronic fatigue syndrome fails large trial

By Clare Wilson
9 April 2019
© Copyright New Scientist Ltd.

A medicine that people hoped would treat chronic fatigue syndrome (CFS) has failed its first large placebo-controlled trial.

The drug, called rituximab, is used to treat cancer and autoimmune diseases in which the immune system makes antibodies that turn against the body. The medicine works by killing the cells that make antibodies.

A few people who had cancer and also happened to have CFS saw their symptoms of fatigue resolve after taking rituximab. Øystein Fluge of Haukeland University Hospital in Norway thought …

 

Full article (subscription required)…

 


 

blog comments powered by Disqus
Previous Previous Page